Global Recombinant Humanized Collagen Market Growth 2026-2032

Product Code: 2020088

Industry: Pharma & Healthcare

Published: Jul 09,2026

Pages: 99

Delivery Time: 2-3 business days

Global Recombinant Humanized Collagen Market Growth 2026-2032

Product Code: 2020088

Industry: Pharma & Healthcare

Published: Jul 09,2026

Pages: 99

Delivery Time: 2-3 business days

Select A Format

Single User License

USD3660

Multi Users License

USD5490

Corporate Users License

USD7320

Buy Now

Add To Cart

Or More Options：

PDF Download

Sample Request

Custom Request

Provide market analysis and obtain sources of data reports

Description

The global Recombinant Humanized Collagen market size is predicted to grow from US$ 110 million in 2025 to US$ 806 million in 2032; it is expected to grow at a CAGR of 32.4% from 2026 to 2032.

Recombinant humanized collagen refers to the introduction of collagen sequences encoded by human genes into cells for expression and production through gene recombination technology to obtain proteins with the same or similar structural and biological characteristics as natural collagen. Recombinant humanized collagen has many advantages, such as controllable production process, high purity, non-infectiousness, etc. It has a wide range of application prospects in medicine, biotechnology, cosmetics and other fields. Recombinant humanized collagen can be used as a biological material in tissue repair and regenerative medicine, including muscles, bones, soft tissues, etc. In addition, it can also be used as a drug carrier for sustained-release drugs, such as heparin, thiazolidinone, etc., to improve the stability and bioavailability of the drug. At the same time, it can also be used to produce medical devices and medical materials such as artificial skin and artificial cornea. Recombinant humanized collagen can be used in cell culture, gene transfection, vaccine production and other aspects. It can act as a scaffold or matrix in cell culture and gene transfection, improve cell adhesion and proliferation, and promote the development of tissue engineering and stem cell research. In terms of vaccine production, recombinant humanized collagen can be used as a vaccine carrier to improve the immunogenicity and efficacy of the vaccine. Recombinant humanized collagen can be used as an ingredient for efficient anti-wrinkle, moisturizing and skin repair, and is widely used in skin care products, makeup and other products. Recombinant humanized collagen has the same amino acid sequence and tertiary structure as natural collagen, which can act directly on the skin, promote the regeneration and repair of skin cells, and improve the elasticity and gloss of the skin.The Medical Device Standard Management Center of the State Food and Drug Administration issued an interpretation of the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials", which divides recombinant humanized collagen into two types, type A and type B based on whether it contains non-human collagen amino acid sequences. Type A refers to materials that do not contain non-human collagen amino acid sequences, including full-length amino acid sequences encoded by human collagen specific type genes (without triple helical structure), or partial amino acid sequence fragments encoded by human collagen specific type genes, or a combination of human collagen functional fragments (the amino acid sequences do not contain non-human collagen amino acid sequences such as linking amino acids and tag amino acids). Type B refers to the material that adds non-human collagen amino acid sequences such as amino acids and tag amino acids based on the combination of human collagen functional fragments.In 2025, global Recombinant Humanized Collagen production reached approximately 35.67 Tons, with an average global market price of around US$ 3,162 per kg.

Compared with animal-derived collagen, recombinant collagen has a series of obvious advantages, including higher biological activity and biocompatibility, lower immunogenicity, lower risk of missed pathogens, better water solubility, non-cytotoxicity, and can be further processed and optimized. In addition, the denaturing temperature of recombinant collagen exceeds 72°C, which is much higher than 40°C for animal-derived collagen, which makes it more stable during transportation and storage. Therefore, as a safer material, recombinant collagen is more suitable for beauty and health products. With the advancement of the industry and the development of technology, its popularity and market penetration are gradually increasing. According to the "Guiding Principles for the Naming of Recombinant Collagen Biomaterials", recombinant collagen is divided into three main categories: recombinant human collagen, recombinant humanized collagen and recombinant collagen. The core differences in these three types of recombinant collagen are reflected in the construction of expression systems, host selection, protein expression, etc. As the homologous and similarity of gene sequences increases, the expression efficiency and biological activity function of collagen vectors will also be improved accordingly.

LP Information, Inc. (LPI) ' newest research report, the “Recombinant Humanized Collagen Industry Forecast” looks at past sales and reviews total world Recombinant Humanized Collagen sales in 2025, providing a comprehensive analysis by region and market sector of projected Recombinant Humanized Collagen sales for 2026 through 2032. With Recombinant Humanized Collagen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Humanized Collagen industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Humanized Collagen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Humanized Collagen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Humanized Collagen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Humanized Collagen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Humanized Collagen.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Humanized Collagen market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Type A
    Type B

Segmentation by Collagen Category:
    Recombinant Type I Collagen Protein
    Recombinant Type Ⅲ Collagen Protein
    Recombinant Type XVII Collagen Protein

Segmentation by Product Form:
    Liquid
    Solid

Segmentation by Application:
    Medical Aesthetics
    Functional Skincare Products
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

    CollPlant
    ProColl
    Gelita AG
    Jellatech
    HTL Biotechnology
    Giant Biogene
    Shanxi Jinbo Bio-Pharmaceutical
    Jiangsu JLand Biotech
    Jiangsu Chuangjian Medical Technology
    Bloomage Biotech

Key Questions Addressed in this Report
What is the 10-year outlook for the global Recombinant Humanized Collagen market?
What factors are driving Recombinant Humanized Collagen market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Humanized Collagen market opportunities vary by end market size?
How does Recombinant Humanized Collagen break out by Type, by Application?

Table Of Contents

1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
    1.8 Market Estimation Caveats

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Recombinant Humanized Collagen Annual Sales 2021-2032
        2.1.2 World Current & Future Analysis for Recombinant Humanized Collagen by Geographic Region, 2021, 2025 & 2032
        2.1.3 World Current & Future Analysis for Recombinant Humanized Collagen by Country/Region, 2021, 2025 & 2032
    2.2 Recombinant Humanized Collagen Segment by Type
        2.2.1 Type A
        2.2.2 Type B
        2.2.3 Recombinant Humanized Collagen Sales by Type
            2.2.3.1 Global Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
            2.2.3.2 Global Recombinant Humanized Collagen Revenue and Market Share by Type (2021-2026)
            2.2.3.3 Global Recombinant Humanized Collagen Sale Price by Type (2021-2026)
    2.3 Recombinant Humanized Collagen Segment by Collagen Category
        2.3.1 Recombinant Type I Collagen Protein
        2.3.2 Recombinant Type Ⅲ Collagen Protein
        2.3.3 Recombinant Type XVII Collagen Protein
        2.3.4 Recombinant Humanized Collagen Sales by Collagen Category
            2.3.4.1 Global Recombinant Humanized Collagen Sales Market Share by Collagen Category (2021-2026)
            2.3.4.2 Global Recombinant Humanized Collagen Revenue and Market Share by Collagen Category (2021-2026)
            2.3.4.3 Global Recombinant Humanized Collagen Sale Price by Collagen Category (2021-2026)
    2.4 Recombinant Humanized Collagen Segment by Product Form
        2.4.1 Liquid
        2.4.2 Solid
        2.4.3 Recombinant Humanized Collagen Sales by Product Form
            2.4.3.1 Global Recombinant Humanized Collagen Sales Market Share by Product Form (2021-2026)
            2.4.3.2 Global Recombinant Humanized Collagen Revenue and Market Share by Product Form (2021-2026)
            2.4.3.3 Global Recombinant Humanized Collagen Sale Price by Product Form (2021-2026)
    2.5 Recombinant Humanized Collagen Segment by Application
        2.5.1 Medical Aesthetics
        2.5.2 Functional Skincare Products
        2.5.3 Others
        2.5.4 Recombinant Humanized Collagen Sales by Application
            2.5.4.1 Global Recombinant Humanized Collagen Sale Market Share by Application (2021-2026)
            2.5.4.2 Global Recombinant Humanized Collagen Revenue and Market Share by Application (2021-2026)
            2.5.4.3 Global Recombinant Humanized Collagen Sale Price by Application (2021-2026)

3 Global by Company
    3.1 Global Recombinant Humanized Collagen Breakdown Data by Company
        3.1.1 Global Recombinant Humanized Collagen Annual Sales by Company (2021-2026)
        3.1.2 Global Recombinant Humanized Collagen Sales Market Share by Company (2021-2026)
    3.2 Global Recombinant Humanized Collagen Annual Revenue by Company (2021-2026)
        3.2.1 Global Recombinant Humanized Collagen Revenue by Company (2021-2026)
        3.2.2 Global Recombinant Humanized Collagen Revenue Market Share by Company (2021-2026)
    3.3 Global Recombinant Humanized Collagen Sale Price by Company
    3.4 Key Manufacturers Recombinant Humanized Collagen Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Recombinant Humanized Collagen Product Location Distribution
        3.4.2 Players Recombinant Humanized Collagen Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    3.6 New Products and Potential Entrants
    3.7 Market M&A Activity & Strategy

4 World Historic Review for Recombinant Humanized Collagen by Geographic Region
    4.1 World Historic Recombinant Humanized Collagen Market Size by Geographic Region (2021-2026)
        4.1.1 Global Recombinant Humanized Collagen Annual Sales by Geographic Region (2021-2026)
        4.1.2 Global Recombinant Humanized Collagen Annual Revenue by Geographic Region (2021-2026)
    4.2 World Historic Recombinant Humanized Collagen Market Size by Country/Region (2021-2026)
        4.2.1 Global Recombinant Humanized Collagen Annual Sales by Country/Region (2021-2026)
        4.2.2 Global Recombinant Humanized Collagen Annual Revenue by Country/Region (2021-2026)
    4.3 Americas Recombinant Humanized Collagen Sales Growth
    4.4 APAC Recombinant Humanized Collagen Sales Growth
    4.5 Europe Recombinant Humanized Collagen Sales Growth
    4.6 Middle East & Africa Recombinant Humanized Collagen Sales Growth

5 Americas
    5.1 Americas Recombinant Humanized Collagen Sales by Country
        5.1.1 Americas Recombinant Humanized Collagen Sales by Country (2021-2026)
        5.1.2 Americas Recombinant Humanized Collagen Revenue by Country (2021-2026)
    5.2 Americas Recombinant Humanized Collagen Sales by Type (2021-2026)
    5.3 Americas Recombinant Humanized Collagen Sales by Application (2021-2026)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil

6 APAC
    6.1 APAC Recombinant Humanized Collagen Sales by Region
        6.1.1 APAC Recombinant Humanized Collagen Sales by Region (2021-2026)
        6.1.2 APAC Recombinant Humanized Collagen Revenue by Region (2021-2026)
    6.2 APAC Recombinant Humanized Collagen Sales by Type (2021-2026)
    6.3 APAC Recombinant Humanized Collagen Sales by Application (2021-2026)
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan

7 Europe
    7.1 Europe Recombinant Humanized Collagen by Country
        7.1.1 Europe Recombinant Humanized Collagen Sales by Country (2021-2026)
        7.1.2 Europe Recombinant Humanized Collagen Revenue by Country (2021-2026)
    7.2 Europe Recombinant Humanized Collagen Sales by Type (2021-2026)
    7.3 Europe Recombinant Humanized Collagen Sales by Application (2021-2026)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia

8 Middle East & Africa
    8.1 Middle East & Africa Recombinant Humanized Collagen by Country
        8.1.1 Middle East & Africa Recombinant Humanized Collagen Sales by Country (2021-2026)
        8.1.2 Middle East & Africa Recombinant Humanized Collagen Revenue by Country (2021-2026)
    8.2 Middle East & Africa Recombinant Humanized Collagen Sales by Type (2021-2026)
    8.3 Middle East & Africa Recombinant Humanized Collagen Sales by Application (2021-2026)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Recombinant Humanized Collagen
    10.3 Manufacturing Process Analysis of Recombinant Humanized Collagen
    10.4 Industry Chain Structure of Recombinant Humanized Collagen

11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Recombinant Humanized Collagen Distributors
    11.3 Recombinant Humanized Collagen Customer

12 World Forecast Review for Recombinant Humanized Collagen by Geographic Region
    12.1 Global Recombinant Humanized Collagen Market Size Forecast by Region
        12.1.1 Global Recombinant Humanized Collagen Forecast by Region (2027-2032)
        12.1.2 Global Recombinant Humanized Collagen Annual Revenue Forecast by Region (2027-2032)
    12.2 Americas Forecast by Country (2027-2032)
    12.3 APAC Forecast by Region (2027-2032)
    12.4 Europe Forecast by Country (2027-2032)
    12.5 Middle East & Africa Forecast by Country (2027-2032)
    12.6 Global Recombinant Humanized Collagen Forecast by Type (2027-2032)
    12.7 Global Recombinant Humanized Collagen Forecast by Application (2027-2032)

13 Key Players Analysis
    13.1 CollPlant
        13.1.1 CollPlant Company Information
        13.1.2 CollPlant Recombinant Humanized Collagen Product Portfolios and Specifications
        13.1.3 CollPlant Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.1.4 CollPlant Main Business Overview
        13.1.5 CollPlant Latest Developments
    13.2 ProColl
        13.2.1 ProColl Company Information
        13.2.2 ProColl Recombinant Humanized Collagen Product Portfolios and Specifications
        13.2.3 ProColl Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.2.4 ProColl Main Business Overview
        13.2.5 ProColl Latest Developments
    13.3 Gelita AG
        13.3.1 Gelita AG Company Information
        13.3.2 Gelita AG Recombinant Humanized Collagen Product Portfolios and Specifications
        13.3.3 Gelita AG Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.3.4 Gelita AG Main Business Overview
        13.3.5 Gelita AG Latest Developments
    13.4 Jellatech
        13.4.1 Jellatech Company Information
        13.4.2 Jellatech Recombinant Humanized Collagen Product Portfolios and Specifications
        13.4.3 Jellatech Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.4.4 Jellatech Main Business Overview
        13.4.5 Jellatech Latest Developments
    13.5 HTL Biotechnology
        13.5.1 HTL Biotechnology Company Information
        13.5.2 HTL Biotechnology Recombinant Humanized Collagen Product Portfolios and Specifications
        13.5.3 HTL Biotechnology Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.5.4 HTL Biotechnology Main Business Overview
        13.5.5 HTL Biotechnology Latest Developments
    13.6 Giant Biogene
        13.6.1 Giant Biogene Company Information
        13.6.2 Giant Biogene Recombinant Humanized Collagen Product Portfolios and Specifications
        13.6.3 Giant Biogene Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.6.4 Giant Biogene Main Business Overview
        13.6.5 Giant Biogene Latest Developments
    13.7 Shanxi Jinbo Bio-Pharmaceutical
        13.7.1 Shanxi Jinbo Bio-Pharmaceutical Company Information
        13.7.2 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolios and Specifications
        13.7.3 Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.7.4 Shanxi Jinbo Bio-Pharmaceutical Main Business Overview
        13.7.5 Shanxi Jinbo Bio-Pharmaceutical Latest Developments
    13.8 Jiangsu JLand Biotech
        13.8.1 Jiangsu JLand Biotech Company Information
        13.8.2 Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolios and Specifications
        13.8.3 Jiangsu JLand Biotech Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.8.4 Jiangsu JLand Biotech Main Business Overview
        13.8.5 Jiangsu JLand Biotech Latest Developments
    13.9 Jiangsu Chuangjian Medical Technology
        13.9.1 Jiangsu Chuangjian Medical Technology Company Information
        13.9.2 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolios and Specifications
        13.9.3 Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.9.4 Jiangsu Chuangjian Medical Technology Main Business Overview
        13.9.5 Jiangsu Chuangjian Medical Technology Latest Developments
    13.10 Bloomage Biotech
        13.10.1 Bloomage Biotech Company Information
        13.10.2 Bloomage Biotech Recombinant Humanized Collagen Product Portfolios and Specifications
        13.10.3 Bloomage Biotech Recombinant Humanized Collagen Sales, Revenue, Price and Gross Margin (2021-2026)
        13.10.4 Bloomage Biotech Main Business Overview
        13.10.5 Bloomage Biotech Latest Developments

14 Research Findings and Conclusion

List Of Tables

List of Tables
 Table 1. Recombinant Humanized Collagen Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Table 2. Recombinant Humanized Collagen Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
 Table 3. Major Players of Type A
 Table 4. Major Players of Type B
 Table 5. Global Recombinant Humanized Collagen Sales by Type (2021-2026) & (Tons)
 Table 6. Global Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
 Table 7. Global Recombinant Humanized Collagen Revenue by Type (2021-2026) & ($ million)
 Table 8. Global Recombinant Humanized Collagen Revenue Market Share by Type (2021-2026)
 Table 9. Global Recombinant Humanized Collagen Sale Price by Type (2021-2026) & (US$/kg)
 Table 10. Major Players of Recombinant Type I Collagen Protein
 Table 11. Major Players of Recombinant Type Ⅲ Collagen Protein
 Table 12. Major Players of Recombinant Type XVII Collagen Protein
 Table 13. Global Recombinant Humanized Collagen Sales by Collagen Category (2021-2026) & (Tons)
 Table 14. Global Recombinant Humanized Collagen Sales Market Share by Collagen Category (2021-2026)
 Table 15. Global Recombinant Humanized Collagen Revenue by Collagen Category (2021-2026) & ($ million)
 Table 16. Global Recombinant Humanized Collagen Revenue Market Share by Collagen Category (2021-2026)
 Table 17. Global Recombinant Humanized Collagen Sale Price by Collagen Category (2021-2026) & (US$/kg)
 Table 18. Major Players of Liquid
 Table 19. Major Players of Solid
 Table 20. Global Recombinant Humanized Collagen Sales by Product Form (2021-2026) & (Tons)
 Table 21. Global Recombinant Humanized Collagen Sales Market Share by Product Form (2021-2026)
 Table 22. Global Recombinant Humanized Collagen Revenue by Product Form (2021-2026) & ($ million)
 Table 23. Global Recombinant Humanized Collagen Revenue Market Share by Product Form (2021-2026)
 Table 24. Global Recombinant Humanized Collagen Sale Price by Product Form (2021-2026) & (US$/kg)
 Table 25. Global Recombinant Humanized Collagen Sale by Application (2021-2026) & (Tons)
 Table 26. Global Recombinant Humanized Collagen Sale Market Share by Application (2021-2026)
 Table 27. Global Recombinant Humanized Collagen Revenue by Application (2021-2026) & ($ million)
 Table 28. Global Recombinant Humanized Collagen Revenue Market Share by Application (2021-2026)
 Table 29. Global Recombinant Humanized Collagen Sale Price by Application (2021-2026) & (US$/kg)
 Table 30. Global Recombinant Humanized Collagen Sales by Company (2021-2026) & (Tons)
 Table 31. Global Recombinant Humanized Collagen Sales Market Share by Company (2021-2026)
 Table 32. Global Recombinant Humanized Collagen Revenue by Company (2021-2026) & ($ millions)
 Table 33. Global Recombinant Humanized Collagen Revenue Market Share by Company (2021-2026)
 Table 34. Global Recombinant Humanized Collagen Sale Price by Company (2021-2026) & (US$/kg)
 Table 35. Key Manufacturers Recombinant Humanized Collagen Producing Area Distribution and Sales Area
 Table 36. Players Recombinant Humanized Collagen Products Offered
 Table 37. Recombinant Humanized Collagen Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
 Table 38. New Products and Potential Entrants
 Table 39. Market M&A Activity & Strategy
 Table 40. Global Recombinant Humanized Collagen Sales by Geographic Region (2021-2026) & (Tons)
 Table 41. Global Recombinant Humanized Collagen Sales Market Share Geographic Region (2021-2026)
 Table 42. Global Recombinant Humanized Collagen Revenue by Geographic Region (2021-2026) & ($ millions)
 Table 43. Global Recombinant Humanized Collagen Revenue Market Share by Geographic Region (2021-2026)
 Table 44. Global Recombinant Humanized Collagen Sales by Country/Region (2021-2026) & (Tons)
 Table 45. Global Recombinant Humanized Collagen Sales Market Share by Country/Region (2021-2026)
 Table 46. Global Recombinant Humanized Collagen Revenue by Country/Region (2021-2026) & ($ millions)
 Table 47. Global Recombinant Humanized Collagen Revenue Market Share by Country/Region (2021-2026)
 Table 48. Americas Recombinant Humanized Collagen Sales by Country (2021-2026) & (Tons)
 Table 49. Americas Recombinant Humanized Collagen Sales Market Share by Country (2021-2026)
 Table 50. Americas Recombinant Humanized Collagen Revenue by Country (2021-2026) & ($ millions)
 Table 51. Americas Recombinant Humanized Collagen Sales by Type (2021-2026) & (Tons)
 Table 52. Americas Recombinant Humanized Collagen Sales by Application (2021-2026) & (Tons)
 Table 53. APAC Recombinant Humanized Collagen Sales by Region (2021-2026) & (Tons)
 Table 54. APAC Recombinant Humanized Collagen Sales Market Share by Region (2021-2026)
 Table 55. APAC Recombinant Humanized Collagen Revenue by Region (2021-2026) & ($ millions)
 Table 56. APAC Recombinant Humanized Collagen Sales by Type (2021-2026) & (Tons)
 Table 57. APAC Recombinant Humanized Collagen Sales by Application (2021-2026) & (Tons)
 Table 58. Europe Recombinant Humanized Collagen Sales by Country (2021-2026) & (Tons)
 Table 59. Europe Recombinant Humanized Collagen Revenue by Country (2021-2026) & ($ millions)
 Table 60. Europe Recombinant Humanized Collagen Sales by Type (2021-2026) & (Tons)
 Table 61. Europe Recombinant Humanized Collagen Sales by Application (2021-2026) & (Tons)
 Table 62. Middle East & Africa Recombinant Humanized Collagen Sales by Country (2021-2026) & (Tons)
 Table 63. Middle East & Africa Recombinant Humanized Collagen Revenue Market Share by Country (2021-2026)
 Table 64. Middle East & Africa Recombinant Humanized Collagen Sales by Type (2021-2026) & (Tons)
 Table 65. Middle East & Africa Recombinant Humanized Collagen Sales by Application (2021-2026) & (Tons)
 Table 66. Key Market Drivers & Growth Opportunities of Recombinant Humanized Collagen
 Table 67. Key Market Challenges & Risks of Recombinant Humanized Collagen
 Table 68. Key Industry Trends of Recombinant Humanized Collagen
 Table 69. Recombinant Humanized Collagen Raw Material
 Table 70. Key Suppliers of Raw Materials
 Table 71. Recombinant Humanized Collagen Distributors List
 Table 72. Recombinant Humanized Collagen Customer List
 Table 73. Global Recombinant Humanized Collagen Sales Forecast by Region (2027-2032) & (Tons)
 Table 74. Global Recombinant Humanized Collagen Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 75. Americas Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (Tons)
 Table 76. Americas Recombinant Humanized Collagen Annual Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 77. APAC Recombinant Humanized Collagen Sales Forecast by Region (2027-2032) & (Tons)
 Table 78. APAC Recombinant Humanized Collagen Annual Revenue Forecast by Region (2027-2032) & ($ millions)
 Table 79. Europe Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (Tons)
 Table 80. Europe Recombinant Humanized Collagen Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 81. Middle East & Africa Recombinant Humanized Collagen Sales Forecast by Country (2027-2032) & (Tons)
 Table 82. Middle East & Africa Recombinant Humanized Collagen Revenue Forecast by Country (2027-2032) & ($ millions)
 Table 83. Global Recombinant Humanized Collagen Sales Forecast by Type (2027-2032) & (Tons)
 Table 84. Global Recombinant Humanized Collagen Revenue Forecast by Type (2027-2032) & ($ millions)
 Table 85. Global Recombinant Humanized Collagen Sales Forecast by Application (2027-2032) & (Tons)
 Table 86. Global Recombinant Humanized Collagen Revenue Forecast by Application (2027-2032) & ($ millions)
 Table 87. CollPlant Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 88. CollPlant Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 89. CollPlant Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 90. CollPlant Main Business
 Table 91. CollPlant Latest Developments
 Table 92. ProColl Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 93. ProColl Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 94. ProColl Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 95. ProColl Main Business
 Table 96. ProColl Latest Developments
 Table 97. Gelita AG Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 98. Gelita AG Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 99. Gelita AG Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 100. Gelita AG Main Business
 Table 101. Gelita AG Latest Developments
 Table 102. Jellatech Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 103. Jellatech Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 104. Jellatech Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 105. Jellatech Main Business
 Table 106. Jellatech Latest Developments
 Table 107. HTL Biotechnology Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 108. HTL Biotechnology Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 109. HTL Biotechnology Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 110. HTL Biotechnology Main Business
 Table 111. HTL Biotechnology Latest Developments
 Table 112. Giant Biogene Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 113. Giant Biogene Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 114. Giant Biogene Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 115. Giant Biogene Main Business
 Table 116. Giant Biogene Latest Developments
 Table 117. Shanxi Jinbo Bio-Pharmaceutical Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 118. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 119. Shanxi Jinbo Bio-Pharmaceutical Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 120. Shanxi Jinbo Bio-Pharmaceutical Main Business
 Table 121. Shanxi Jinbo Bio-Pharmaceutical Latest Developments
 Table 122. Jiangsu JLand Biotech Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 123. Jiangsu JLand Biotech Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 124. Jiangsu JLand Biotech Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 125. Jiangsu JLand Biotech Main Business
 Table 126. Jiangsu JLand Biotech Latest Developments
 Table 127. Jiangsu Chuangjian Medical Technology Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 128. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 129. Jiangsu Chuangjian Medical Technology Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 130. Jiangsu Chuangjian Medical Technology Main Business
 Table 131. Jiangsu Chuangjian Medical Technology Latest Developments
 Table 132. Bloomage Biotech Basic Information, Recombinant Humanized Collagen Manufacturing Base, Sales Area and Its Competitors
 Table 133. Bloomage Biotech Recombinant Humanized Collagen Product Portfolios and Specifications
 Table 134. Bloomage Biotech Recombinant Humanized Collagen Sales (Tons), Revenue ($ Million), Price (US$/kg) and Gross Margin (2021-2026)
 Table 135. Bloomage Biotech Main Business
 Table 136. Bloomage Biotech Latest Developments


List of Figures
 Figure 1. Picture of Recombinant Humanized Collagen
 Figure 2. Recombinant Humanized Collagen Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global Recombinant Humanized Collagen Sales Growth Rate 2021-2032 (Tons)
 Figure 7. Global Recombinant Humanized Collagen Revenue Growth Rate 2021-2032 ($ millions)
 Figure 8. Recombinant Humanized Collagen Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
 Figure 9. Recombinant Humanized Collagen Sales Market Share by Country/Region (2025)
 Figure 10. Recombinant Humanized Collagen Sales Market Share by Country/Region (2021, 2025 & 2032)
 Figure 11. Product Picture of Type A
 Figure 12. Product Picture of Type B
 Figure 13. Global Recombinant Humanized Collagen Sales Market Share by Type in 2026
 Figure 14. Global Recombinant Humanized Collagen Revenue Market Share by Type (2021-2026)
 Figure 15. Product Picture of Recombinant Type I Collagen Protein
 Figure 16. Product Picture of Recombinant Type Ⅲ Collagen Protein
 Figure 17. Product Picture of Recombinant Type XVII Collagen Protein
 Figure 18. Global Recombinant Humanized Collagen Sales Market Share by Collagen Category in 2026
 Figure 19. Global Recombinant Humanized Collagen Revenue Market Share by Collagen Category (2021-2026)
 Figure 20. Product Picture of Liquid
 Figure 21. Product Picture of Solid
 Figure 22. Global Recombinant Humanized Collagen Sales Market Share by Product Form in 2026
 Figure 23. Global Recombinant Humanized Collagen Revenue Market Share by Product Form (2021-2026)
 Figure 24. Recombinant Humanized Collagen Consumed in Medical Aesthetics
 Figure 25. Global Recombinant Humanized Collagen Market: Medical Aesthetics (2021-2026) & (Tons)
 Figure 26. Recombinant Humanized Collagen Consumed in Functional Skincare Products
 Figure 27. Global Recombinant Humanized Collagen Market: Functional Skincare Products (2021-2026) & (Tons)
 Figure 28. Recombinant Humanized Collagen Consumed in Others
 Figure 29. Global Recombinant Humanized Collagen Market: Others (2021-2026) & (Tons)
 Figure 30. Global Recombinant Humanized Collagen Sale Market Share by Application (2025)
 Figure 31. Global Recombinant Humanized Collagen Revenue Market Share by Application in 2025
 Figure 32. Recombinant Humanized Collagen Sales by Company in 2025 (Tons)
 Figure 33. Global Recombinant Humanized Collagen Sales Market Share by Company in 2025
 Figure 34. Recombinant Humanized Collagen Revenue by Company in 2025 ($ millions)
 Figure 35. Global Recombinant Humanized Collagen Revenue Market Share by Company in 2025
 Figure 36. Global Recombinant Humanized Collagen Sales Market Share by Geographic Region (2021-2026)
 Figure 37. Global Recombinant Humanized Collagen Revenue Market Share by Geographic Region in 2025
 Figure 38. Americas Recombinant Humanized Collagen Sales 2021-2026 (Tons)
 Figure 39. Americas Recombinant Humanized Collagen Revenue 2021-2026 ($ millions)
 Figure 40. APAC Recombinant Humanized Collagen Sales 2021-2026 (Tons)
 Figure 41. APAC Recombinant Humanized Collagen Revenue 2021-2026 ($ millions)
 Figure 42. Europe Recombinant Humanized Collagen Sales 2021-2026 (Tons)
 Figure 43. Europe Recombinant Humanized Collagen Revenue 2021-2026 ($ millions)
 Figure 44. Middle East & Africa Recombinant Humanized Collagen Sales 2021-2026 (Tons)
 Figure 45. Middle East & Africa Recombinant Humanized Collagen Revenue 2021-2026 ($ millions)
 Figure 46. Americas Recombinant Humanized Collagen Sales Market Share by Country in 2025
 Figure 47. Americas Recombinant Humanized Collagen Revenue Market Share by Country (2021-2026)
 Figure 48. Americas Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
 Figure 49. Americas Recombinant Humanized Collagen Sales Market Share by Application (2021-2026)
 Figure 50. United States Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 51. Canada Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 52. Mexico Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 53. Brazil Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 54. APAC Recombinant Humanized Collagen Sales Market Share by Region in 2025
 Figure 55. APAC Recombinant Humanized Collagen Revenue Market Share by Region (2021-2026)
 Figure 56. APAC Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
 Figure 57. APAC Recombinant Humanized Collagen Sales Market Share by Application (2021-2026)
 Figure 58. China Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 59. Japan Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 60. South Korea Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 61. Southeast Asia Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 62. India Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 63. Australia Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 64. China Taiwan Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 65. Europe Recombinant Humanized Collagen Sales Market Share by Country in 2025
 Figure 66. Europe Recombinant Humanized Collagen Revenue Market Share by Country (2021-2026)
 Figure 67. Europe Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
 Figure 68. Europe Recombinant Humanized Collagen Sales Market Share by Application (2021-2026)
 Figure 69. Germany Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 70. France Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 71. UK Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 72. Italy Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 73. Russia Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 74. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Country (2021-2026)
 Figure 75. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Type (2021-2026)
 Figure 76. Middle East & Africa Recombinant Humanized Collagen Sales Market Share by Application (2021-2026)
 Figure 77. Egypt Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 78. South Africa Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 79. Israel Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 80. Turkey Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 81. GCC Countries Recombinant Humanized Collagen Revenue Growth 2021-2026 ($ millions)
 Figure 82. Manufacturing Cost Structure Analysis of Recombinant Humanized Collagen in 2026
 Figure 83. Manufacturing Process Analysis of Recombinant Humanized Collagen
 Figure 84. Industry Chain Structure of Recombinant Humanized Collagen
 Figure 85. Channels of Distribution
 Figure 86. Global Recombinant Humanized Collagen Sales Market Forecast by Region (2027-2032)
 Figure 87. Global Recombinant Humanized Collagen Revenue Market Share Forecast by Region (2027-2032)
 Figure 88. Global Recombinant Humanized Collagen Sales Market Share Forecast by Type (2027-2032)
 Figure 89. Global Recombinant Humanized Collagen Revenue Market Share Forecast by Type (2027-2032)
 Figure 90. Global Recombinant Humanized Collagen Sales Market Share Forecast by Application (2027-2032)
 Figure 91. Global Recombinant Humanized Collagen Revenue Market Share Forecast by Application (2027-2032)

Companies Mentioned

CollPlant

ProColl

Gelita AG

Jellatech

HTL Biotechnology

Giant Biogene

Shanxi Jinbo Bio-Pharmaceutical

Jiangsu JLand Biotech

Jiangsu Chuangjian Medical Technology

Bloomage Biotech

Methodology

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

Data Sourse

Primary Source

Secondary Source

Players/Suppliers

Journals and Periodicals

Industry Experts

Government Bodies

Distributors/Traders

Annual Reports

Opinion Leaders

Presentations

Front-line Staff